Cytek Biosciences CTKB Cash Flow Statement (2020-2026)

NASDAQ CTKB
$5.84 +0.08 (+1.48%)
As of: Sep 30, 2026 · 12:07 PM EDT
Reported Financials

Cytek Biosciences Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Cytek Biosciences reported cash from operations of $1.37M and free cash flow of -$0.85M for the quarter ended Jun 2026. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
1.42M-1.17M-2.16M-0.70M1.63M3.72M-6.81M-4.39M-6.46M5.50M-6.17M-10.43M0.94M9.64M-11.40M-5.58M-5.48M-44.08M-18.87M-12.16M
Depreciation and DepletionDep. & Depletion
0.19M0.35M0.30M0.40M0.40M0.50M0.50M0.60M0.90M0.80M0.80M0.90M0.90M0.90M0.90M1.00M1.00M1.00M1.00M1.10M
Share-based CompensationStock Comp.
2.46M3.01M3.84M4.40M4.36M4.46M4.70M5.92M5.76M5.67M5.64M7.15M7.05M7.00M6.63M6.79M5.64M5.53M4.86M5.34M
Deferred Taxes
-2.89M-0.34M-2.06M-2.63M38.58M-0.18M
Gains from Sales and DivestituresGains Divest
-0.01M-0.05M-0.01M-0.00M-0.10M-0.15M-0.10M-0.06M-0.06M-0.14M
Asset Writedowns and ImpairmentWritedown
0.07M0.15M0.07M0.21M0.17M0.29M0.51M0.09M0.20M0.67M0.91M0.12M0.34M0.27M0.31M0.02M0.13M1.24M0.19M0.44M
Cash from OperationsCash from Ops.
1.16M5.45M-1.48M-9.44M-7.50M6.19M2.86M-2.85M-4.24M9.51M3.96M6.20M13.22M2.00M-0.12M0.11M-3.90M-0.77M-2.74M1.37M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.19M0.69M0.79M0.86M0.07M0.76M1.00M1.65M1.77M1.63M1.70M1.81M1.85M1.85M1.88M1.89M1.92M1.90M1.86M2.01M
Change in Working Capital
Change in ReceivablesChange Receivables
5.59M0.72M1.04M6.93M3.82M7.96M-6.05M6.80M6.85M-0.26M-4.24M-5.92M6.25M9.33M-6.45M-0.65M0.59M6.15M-9.64M-1.97M
Change in InventoryChange Inventory
0.96M2.23M5.92M8.43M5.18M-1.88M3.19M-3.03M1.89M-6.33M-4.77M-4.43M-3.56M-2.00M1.50M3.57M2.22M-2.05M1.63M2.86M
Change in Account PayablesChange Payables
0.64M-0.74M2.78M0.90M-0.91M-0.91M0.30M-2.00M1.71M-1.79M0.61M-0.52M2.23M0.26M0.41M0.76M0.59M-1.31M0.39M1.74M
Change in Accured ExpensesChange Accured Exp.
1.59M8.88M0.56M2.23M0.04M4.64M1.76M-1.49M0.34M0.12M-4.60M-4.79M5.63M2.94M-2.12M2.79M-1.41M4.71M-3.89M4.12M
Other Working Capital ChangesOther WC Changes
2.71M3.38M4.35M4.31M6.37M4.33M-0.71M6.43M1.50M2.30M2.92M-4.08M3.50M1.39M1.34M-3.54M-1.08M6.88M-3.85M5.78M
Investing Activities
Capital ExpendituresCapex
1.31M1.30M0.78M1.33M1.11M6.53M0.51M1.31M1.33M1.50M0.57M1.05M1.01M0.89M0.85M1.58M0.66M1.00M2.17M2.22M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.08M0.02M0.19M0.03M0.02M0.00M0.20M0.01M0.00M
Change in IntangiblesChange Intangibless
0.04M0.08M0.06M0.06M0.06M0.06M0.15M-0.01M0.01M0.00M0.07M-0.00M0.03M0.03M0.03M
Acquisitions
17.00M1.59M44.90M0.00M0.47M
Cash from Investing ActivitiesCash from Investing
-1.31M-18.30M-0.78M-2.92M-1.15M-51.06M-168.87M2.79M43.12M29.07M-5.75M2.02M-15.81M-63.43M9.45M-16.41M18.92M-1.84M-27.08M7.02M
Financing Activities
Cash from Financing ActivitiesCash from Financing
217.08M0.02M0.36M1.14M0.15M3.85M0.22M-8.27M-33.75M1.61M-1.71M-12.08M-3.64M-11.54M-2.60M1.94M-1.23M3.98M-0.81M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
215.37M0.36M0.45M0.23M0.17M0.20M0.76M0.16M0.73M0.51M0.50M0.70M0.04M0.66M0.45M0.02M0.83M
Additional items
Exchange Rate EffectFX Effect
-0.01M0.68M-0.22M-1.40M0.13M-1.00M-1.09M-1.01M1.47M-0.82M1.70M2.26M-0.94M1.52M-1.23M-0.92M0.85M1.41M0.65M0.61M
Change in Cash
-204.38M409.15M-2.11M-12.61M-8.37M-42.02M-167.11M-0.85M32.09M4.00M1.51M8.78M-15.62M-63.56M-3.45M-19.83M17.81M-2.43M-25.19M8.18M
Free Cash FlowFCF
-0.15M4.15M-2.26M-10.77M-8.61M-0.34M2.35M-4.16M-5.57M8.01M3.39M5.15M12.21M1.10M-0.97M-1.47M-4.55M-1.77M-4.90M-0.85M
Net Cash FlowNCF
216.93M-12.83M-1.90M-11.21M-8.50M-41.02M-166.02M0.16M30.61M4.82M-0.18M6.51M-14.67M-65.08M-2.22M-18.91M16.96M-3.84M-25.83M7.58M

Cytek Biosciences Cash Flow Statement API

Pull Cytek Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CTKB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY